| TTM
|
5/31/2026
|
5/31/2025
|
5/31/2024
|
5/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
39,031.56 | 41,649.67 | 46,292.73 | 44,582.81 | 40,199.35 |
| Cost of Revenue
|
-22,964.25 | -23,302.56 | -24,814.58 | -23,743.55 | -23,250.04 |
|
Gross Profit
|
16,067.31 | 18,347.12 | 21,478.14 | 20,839.25 | 16,949.32 |
|
Selling, General and Administrative Expenses
|
-10,083.91 | -10,228.17 | -11,406.82 | -10,971.36 | -9,043.44 |
|
Research and Development Expenses
|
-847.25 | -776 | -444 | -388.48 | -1,096.81 |
|
Operating Income/Expenses
|
-10,931.17 | -11,004.16 | -11,850.82 | -11,359.83 | -10,140.25 |
|
Total Operating Profit/Loss
|
5,136.14 | 7,342.96 | 9,627.33 | 9,479.42 | 6,809.07 |
| Total Net Finance Income/Expense
|
1,641.91 | 1,641.91 | 1,402.44 | 1,426.58 | 698.86 |
|
Other Income/Expense, Non-Operating
|
38.47 | 3.81 | 3.37 | 14.76 | -2.57 |
|
Non-Operating Income/Expenses, Total
|
1,680.38 | 1,645.72 | 1,405.81 | 1,441.34 | 696.29 |
|
Pretax Income
|
6,816.52 | 8,988.67 | 11,033.14 | 10,920.76 | 7,505.36 |
|
Provision for Income Tax
|
14 | -425 | -1,620 | -1,922 | -1,218 |
|
Net Income from Continuing Operations
|
6,830.52 | 8,563.67 | 9,413.14 | 8,998.76 | 6,287.36 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
6,830.52 | 8,563.67 | 9,413.14 | 8,998.76 | 6,287.36 |
|
Net Income after Non-Controlling/Minority Interests
|
6,830.52 | 8,563.67 | 9,413.14 | 8,998.76 | 6,287.36 |
|
Net Income Available to Common Stockholders
|
6,830.52 | 8,563.67 | 9,413.14 | 8,998.76 | 6,287.36 |
|
Diluted Net Income Available to Common Stockholders
|
6,830.52 | 8,563.67 | 9,413.14 | 8,998.76 | 6,287.36 |
| Basic EPS
|
2.15 | 2.70 | 3.01 | 2.68 | 1.79 |
| Diluted EPS
|
2.07 | 2.62 | 2.87 | 2.58 | 1.77 |
|
Basic Weighted Average Shares Outstanding
|
3,204.22 | 3,170.44 | 3,131.13 | 3,353.08 | 3,506.47 |
|
Diluted Weighted Average Shares Outstanding
|
3,303.46 | 3,269.68 | 3,278.69 | 3,488.79 | 3,551.49 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
6,816.52 | 7,346.77 | 9,630.70 | 9,494.18 | 6,806.49 |
|
EBITDA
|
8,816.14 | 9,273.36 | 11,361.77 | 11,191.82 | 8,278.95 |
|
Normalized EBITDA
|
8,816.14 | 10,910.75 | 12,584.28 | 12,239.08 | 8,739.58 |
|
Normalized Income
|
6,830.52 | 10,124.11 | 10,455.94 | 9,857.51 | 6,673.36 |
|
Total Unusual Items
|
0 | 1,637.39 | 1,222.51 | 1,047.25 | 460.63 |
|
Total Unusual Items Excluding Goodwill
|
0 | 1,637.39 | 1,222.51 | 1,047.25 | 460.63 |
|
Tax Effect of Unusual Items
|
0 | 76.96 | 179.71 | 188.51 | 74.62 |
|
Tax Rate, Calculated
|
0.21 | 0.05 | 0.15 | 0.18 | 0.16 |
5/31/2023 - 11/5/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade